Peptide Modificationes
Quelante Peptides
Quid est Chelating Peptides?
Coitus peptides ad metallum chelators (e.g*. DOTA, USUS, etc.) praebet carum aditus ad cancer TEXTUS imaginatione vel therapiae quae onerariis oncotoxins ut cancer cellulis. Interleukin 13 significat moleculae alpha 2 (IL13RA2) est significat moleculae quae overexpressed in malignissimis gliomas (GBMs) sed abest communi cellulis. Nisl ligandi, qui tale moleculum significantem ligant, novam aditum praebere possunt ad gliomatum malignorum curationem. (GBMs). Quia IL13RA2 intrinsece tenetur IL13, Hoc significat moleculae scopum attractivum in therapiis quae cancer cytotoxici moleculis translocate ad glioma malignum. (GBMs) cellulis.Peptide-I linearibus (Pep-1L) perpensum pro facultate ligandi IL13RA2 in iaculis modo, ac per quelante modificationes, et Peptide-I linearibus (Pep-1L) asportare cytotoxin Actinium-225, Ac-225, onto malignis glioma (GBMs) cellulae.
Quelante Peptides ministerium
Communia List
Expressio vel expressio specificae significationis molecularum a cellulis canceris ad synthesim peptidis evolutionem perduxit, quae his moleculis significans oppugnare potest., et MOL Mutationes offert amplis modificationes peptide chelator, inter DOTA et DTPA *.
|
breviarium
|
Full Name
|
|---|---|
|
DOTA |
1,4,7,10-tetraazacyclododecane-N,N,N,N-tetraaceticum acidum |
|
USUS |
1,4,7-triazacyclononane-N,N,N-triaceticum acidum |
|
MATERTERA |
1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraaceticum acidum |
|
DTPA |
acidum diethylenetriaminepentaaceticum |
|
IDA |
Iminodiacetic acidum |
|
CB-TE2A |
4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane |
|
DiAmSar |
1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo[6,6,6]-eicosane |
Citationes Lorem
Novae insights in consilio Bioactive Peptides et Chelating Agentia pro Imaging et Therapy in Oncologia
Multi peptides syntheticae pro diagnosi et therapia carcinomatis humani ortae sunt, secundum eorum facultatem ut receptores specificos in superficie cellae cancri aut membranam cellam penetrare. Modificationes chemica amino catenis acidis signanter emendavit activitatem biologicam, stabilitatem et efficaciam peptidis analoga currently uti anticancer medicamenta vel ut hypotheticas imaginationes tracers. Stabilitas somatostatin, analoga integrina et bombesin in corpore humano significanter auctae sunt per cyclizationem et/vel insertionem amino acidarum non naturalium in sequentia peptide. Praeterea, altiore pharmacokineticarum proprietatum talium analogorum et aliorum (inter cholecystokinin, vasoactivum intestinorum peptide et neurotensin analoga) emendatis PEGylation et glycosylation. Ceterum, Coniugatio peptidarum illorum analogorum cum nexibus novis et chelatoribus bifunctionibus (ut AAZTA, MATERTERA, TENDICULAE, NUMERUS etc.), producit medietatem radiolabelitatis cum dimidia vita aucta et affinitate ligatura superior receptori cognato. Haec recensio praecipuas et recentes modificationes chemicas in amino acidorum sequentiarum inductas describit necnon ligatores et chelatores bifunctionales novos, quae signanter emendaverunt specificitatem et sensus peptidum in diagnosi et therapia oncologica..
Related Peptide Modification Services
peptide glycosylation
peptide glycosylation
GLYCOSYLATIO Peptide est covalens modificatio quae potentia physicochemical proprietas peptidum emendare potest.
Read Morepeptide Phosphorylation
peptide Phosphorylation
Phosphoration fieri potest in Serine (S, Esse), Threonine (T, Thr) et Tyrosine (Y, Tyr) enotatum per phosphoester vinculum formation
Read MoreStapled Peptides
Stapled Peptides
Introductio duarum amino acidarum innaturalium continens α-methyl, α-alkenyl circulos in solidum-aetatis synthesis peptide catenis.
Read MoreCyclic Peptide
Cyclic Peptide
Peptide cyclisation auget stabilitatem conformationis peptidum (ad lineares analoga) et est commune consilium in evolutione peptide.
Read Morepeptide modificatione
Extensive experientia in peptide modificatione, praebens plures vias viable pro inquisitione peptide.
